Literature DB >> 2498926

Effects of fixed ratio size and dose on phencyclidine self-administration by rats.

K L Marquis1, M G Webb, J E Moreton.   

Abstract

Female Sprague-Dawley rats were trained to self-administer phencyclidine (PCP; 0.125, 0.25, or 0.5 mg/kg/injection) on a fixed ratio (FR) schedule of reinforcement under limited access conditions (3 h). Initial training began with cocaine, which was later replaced with ketamine and then one of the three unit doses of PCP. Baseline rates of injection were determined at FR 10. The size of the ratio was then incremented geometrically every fifth daily session. Increasing the ratio resulted in a decrease in the number of injections per session. Furthermore, this decrease was greater for the 0.25 mg/kg dose than for the 0.5 mg/kg unit dose. The self-administration of the 0.125 mg/kg dose was variable and rapidly extinguished upon the increase in fixed ratio. The results indicate that PCP is self-administered by rats under the conditions imposed in this study. Furthermore, the relative reinforcing efficacy of the different unit doses of PCP could be discriminated using this type of response cost procedure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498926     DOI: 10.1007/bf00442246

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  CHRONIC INTRAVENOUS CANNULAS FOR RATS.

Authors:  J R WEEKS; J D DAVIS
Journal:  J Appl Physiol       Date:  1964-05       Impact factor: 3.531

2.  Prediction of abuse liability of drugs using IV self-administration by rats.

Authors:  R J Collins; J R Weeks; M M Cooper; P I Good; R R Russell
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Intravenous self-administration of etonitazene, cocaine and phencyclidine in rats during food deprivation and satiation.

Authors:  M E Carroll; C P France; R A Meisch
Journal:  J Pharmacol Exp Ther       Date:  1981-05       Impact factor: 4.030

4.  Methohexital-reinforced responding in rats: effects of fixed ratio size and injection dose.

Authors:  R Pickens; D Muchow; V DeNoble
Journal:  J Pharmacol Exp Ther       Date:  1981-02       Impact factor: 4.030

5.  A comparison of pentobarbital and cocaine self-administration in rhesus monkeys: effects of dose and fixed-ratio parameter.

Authors:  S R Goldberg; F Hoffmeister; U U Schlichting; W Wuttke
Journal:  J Pharmacol Exp Ther       Date:  1971-11       Impact factor: 4.030

6.  Animal models of intravenous phencyclinoid self-administration.

Authors:  K L Marquis; J E Moreton
Journal:  Pharmacol Biochem Behav       Date:  1987-06       Impact factor: 3.533

7.  Phencyclidine-analogue self-injection by the baboon.

Authors:  S E Lukas; R R Griffiths; J V Brady; R M Wurster
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Intravenous self-administration of phencyclidine and related compounds in the dog.

Authors:  M E Risner
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

9.  Pentobarbital self-administration in rhesus monkeys: drug concentration and fixed-ratio size interactions.

Authors:  G A Lemaire; R A Meisch
Journal:  J Exp Anal Behav       Date:  1984-07       Impact factor: 2.468

10.  Ketamine self-administration by the rhesus monkey.

Authors:  J E Moreton; R A Meisch; L Stark; T Thompson
Journal:  J Pharmacol Exp Ther       Date:  1977-11       Impact factor: 4.030

  10 in total
  11 in total

1.  Behavioral economics of drug self-administration. II. A unit-price analysis of cigarette smoking.

Authors:  W K Bickel; R J DeGrandpre; J R Hughes; S T Higgins
Journal:  J Exp Anal Behav       Date:  1991-03       Impact factor: 2.468

2.  Cocaine and food as reinforcers: effects of reinforcer magnitude and response requirement under second-order fixed-ratio and progressive-ratio schedules.

Authors:  D J Spear; J L Katz
Journal:  J Exp Anal Behav       Date:  1991-09       Impact factor: 2.468

3.  The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.

Authors:  Adam L Halberstadt; Natalia Slepak; James Hyun; Mahalah R Buell; Susan B Powell
Journal:  Psychopharmacology (Berl)       Date:  2016-01-13       Impact factor: 4.530

4.  Comparison of antidepressant-like and abuse-related effects of phencyclidine in rats.

Authors:  Todd M Hillhouse; Joseph H Porter; S Stevens Negus
Journal:  Drug Dev Res       Date:  2014-10-15       Impact factor: 4.360

5.  Phencyclidine-like in vivo effects of methoxetamine in mice and rats.

Authors:  Michael D Berquist; William S Hyatt; Jonathan Bauer-Erickson; Brenda M Gannon; Andrew P Norwood; William E Fantegrossi
Journal:  Neuropharmacology       Date:  2017-08-19       Impact factor: 5.250

Review 6.  Self-administration of cannabinoids by experimental animals and human marijuana smokers.

Authors:  Zuzana Justinova; Steven R Goldberg; Stephen J Heishman; Gianluigi Tanda
Journal:  Pharmacol Biochem Behav       Date:  2005-06       Impact factor: 3.533

7.  Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study.

Authors:  Celia J A Morgan; Ali Mofeez; Brigita Brandner; Lesley Bromley; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2004-01-15       Impact factor: 4.530

8.  Ratio size and cocaine concentration effects on oral cocaine-reinforced behavior.

Authors:  M J Macenski; R A Meisch
Journal:  J Exp Anal Behav       Date:  1998-09       Impact factor: 2.468

9.  Reinforcing effectiveness of nicotine in nonhuman primates: effects of nicotine dose and history of nicotine self-administration.

Authors:  Stephen J Kohut; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2016-04-14       Impact factor: 4.530

10.  Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses.

Authors:  Fernando B de Moura; Alexander Sherwood; Thomas E Prisinzano; Carol A Paronis; Jack Bergman; Stephen J Kohut
Journal:  Pharmacol Biochem Behav       Date:  2021-01-12       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.